Results 6 to 10 of 15

Laboratory Research Arrangements with Referral Sources Require Careful Structuring

USA - November 1 2019 Laboratory arrangements with referral sources have long been subject to scrutiny by federal regulators, and the potential penalties involved can be…

Kayla J. Cristales, Jennifer S. Kreick

Cross Plan Offsetting May Draw ERISA Litigation

USA - April 24 2019 In an opinion issued by the Eighth Circuit on a matter of first-impression, the court in Peterson v. UnitedHealth Group Inc. left insurers rushing to…

Neil Issar, Micah E. Skidmore, Noor Wadi

2018 Year in Review - The False Claims Act

USA - January 16 2019 The False Claims Act, 31 U.S.C. §§ 3729 et seq. (FCA), continued to be a significant focus of government and whistleblower activity in 2018. This Year…

Stacy Brainin, Andrew Guthrie, Neil Issar, Phillip L. Kim, Jennifer S. Kreick, Taryn McDonald, Bill Morrison, Nicole Somerville

Differences and Similarities Between - Federal Anti-Kickback Statute and the 2018 Eliminating Kickbacks in Recovery Act

USA - December 31 2018 The Eliminating Kickbacks in Recovery Act of 2018 (“EKRA”) marks a significant shift in federal oversight of the healthcare industry, applying the…

Kayla Johnson, Jennifer S. Kreick

Guidance to Avoid FCA Liability for Firms Investing in Healthcare

USA - May 8 2018 The United States recently intervened in a lawsuit alleging that a pharmacy violated the False Claims Act, 31 U.S.C. §§ 3729 et seq. (FCA), by paying…

Neil Issar